Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants

<i>PALB2</i> (Partner and localizer of BRCA2) is crucial for repairing DNA double-stranded breaks (DSBs) through homologous recombination (HR). Germline pathogenic variation in <i>PALB2</i> disrupts DNA damage repair and increases the risk of Fanconi Anemia, breast cancer, an...

Full description

Bibliographic Details
Main Authors: Jia Sheng Chian, Jiaheng Li, San Ming Wang
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/14/11343
_version_ 1797589012793262080
author Jia Sheng Chian
Jiaheng Li
San Ming Wang
author_facet Jia Sheng Chian
Jiaheng Li
San Ming Wang
author_sort Jia Sheng Chian
collection DOAJ
description <i>PALB2</i> (Partner and localizer of BRCA2) is crucial for repairing DNA double-stranded breaks (DSBs) through homologous recombination (HR). Germline pathogenic variation in <i>PALB2</i> disrupts DNA damage repair and increases the risk of Fanconi Anemia, breast cancer, and ovarian cancer. Determination of the evolutionary origin of human <i>PALB2</i> variants will promote a deeper understanding of the biological basis of <i>PALB2</i> germline variation and its roles in human diseases. We tested the evolution origin for 1444 human <i>PALB2</i> germline variants, including 484 pathogenic and 960 benign variants. We performed a phylogenic analysis by tracing the variants in 100 vertebrates. However, we found no evidence to show that cross-species conservation was the origin of <i>PALB2</i> germline pathogenic variants, but it is indeed a rich source for <i>PALB2</i> germline benign variants. We performed a paleoanthropological analysis by tracing the variants in over 5000 ancient humans. We identified 50 pathogenic in 71 ancient humans dated from 32,895 to 689 before the present, of which 90.1% were dated within the recent 10,000 years. <i>PALB2</i> benign variants were also highly shared with ancient humans. Data from our study reveal that human <i>PALB2</i> pathogenic variants mostly arose in recent human history.
first_indexed 2024-03-11T01:00:15Z
format Article
id doaj.art-0216d40ce31641d4943e872ffb1b5a73
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T01:00:15Z
publishDate 2023-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-0216d40ce31641d4943e872ffb1b5a732023-11-18T19:37:53ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-07-0124141134310.3390/ijms241411343Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic VariantsJia Sheng Chian0Jiaheng Li1San Ming Wang2MoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, MacaoMoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, MacaoMoE Frontiers Science Center for Precision Oncology, Cancer Center and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macao<i>PALB2</i> (Partner and localizer of BRCA2) is crucial for repairing DNA double-stranded breaks (DSBs) through homologous recombination (HR). Germline pathogenic variation in <i>PALB2</i> disrupts DNA damage repair and increases the risk of Fanconi Anemia, breast cancer, and ovarian cancer. Determination of the evolutionary origin of human <i>PALB2</i> variants will promote a deeper understanding of the biological basis of <i>PALB2</i> germline variation and its roles in human diseases. We tested the evolution origin for 1444 human <i>PALB2</i> germline variants, including 484 pathogenic and 960 benign variants. We performed a phylogenic analysis by tracing the variants in 100 vertebrates. However, we found no evidence to show that cross-species conservation was the origin of <i>PALB2</i> germline pathogenic variants, but it is indeed a rich source for <i>PALB2</i> germline benign variants. We performed a paleoanthropological analysis by tracing the variants in over 5000 ancient humans. We identified 50 pathogenic in 71 ancient humans dated from 32,895 to 689 before the present, of which 90.1% were dated within the recent 10,000 years. <i>PALB2</i> benign variants were also highly shared with ancient humans. Data from our study reveal that human <i>PALB2</i> pathogenic variants mostly arose in recent human history.https://www.mdpi.com/1422-0067/24/14/11343<i>PALB2</i>evolutionary originphylogeneticpaleoanthropology
spellingShingle Jia Sheng Chian
Jiaheng Li
San Ming Wang
Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
International Journal of Molecular Sciences
<i>PALB2</i>
evolutionary origin
phylogenetic
paleoanthropology
title Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
title_full Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
title_fullStr Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
title_full_unstemmed Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
title_short Evolutionary Origin of Human <i>PALB2</i> Germline Pathogenic Variants
title_sort evolutionary origin of human i palb2 i germline pathogenic variants
topic <i>PALB2</i>
evolutionary origin
phylogenetic
paleoanthropology
url https://www.mdpi.com/1422-0067/24/14/11343
work_keys_str_mv AT jiashengchian evolutionaryoriginofhumanipalb2igermlinepathogenicvariants
AT jiahengli evolutionaryoriginofhumanipalb2igermlinepathogenicvariants
AT sanmingwang evolutionaryoriginofhumanipalb2igermlinepathogenicvariants